Expression of S100A9 was also confirmed using primary BM or blood samples of 5 AML patients (Fig. 1H) (patients’ age, % of blasts and FAB subtype is included in Supplemental Table 2). The gene discussed is S100A9; the disease is acute myeloid leukemia.